Let's Play PET References - "L"

[Back to Menu] [Back to Index]
  • Lammertsma A, De Silva R, Araujo L, Jones T. Measurement of regional myocardial blood flow using C15O2 and positron emission tomography: comparison of tracer models. Clin Phys Physiol Measure 13:1-20, 1992.

  • Lammertsma, A, Bench, C, Price, G, Cremer, J, Luthra, S, et al: Measurement of cerebral monoamine oxidase B activity using L-[11-C]deprenyl and dynamic positron emission tomography. J Cereb Blood Flow Metab, 11:545-56, 1991.

  • Latack, J, Abou-Khalil, B, Siegel, G, Sackellares, J, Gabrielsen, T, Aisen, A. Patients with partial seizures: Evaluation by MR, CT, and PET imaging. Radiology 159:159-63, 1986.

  • Laubenbacher, C, Rothley, J, Sitomer, J, Beanlands, R, Sawada, S, Sutor, S, Muller, D, Schwaiger, M: An automated analysis program for the evaluation of cardiac PET studies: Initial results in the detection and localization of coronary artery disease using nitrogen-13 ammonia. J Nucl Med, 34:968-978, 1993.

  • Lear JL; Ackermann RF. Quantification of patterns of regional cardiac metabolism. Radiology, 1990, 176:659-64.

  • Lecomte R. Analytical study of performance in a 3D PET scanner. Phys Med Biol, 1992, 37:623-34.

  • Leenders, K, Salmon, E, Tyrrell, P., et al: The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol, 47:1290-8, 1990.

  • Leenders, K: Characterization of Parkinson's disease using positron emission tomography. In: Dostert, P, et al., Eds. Early Markers in Parkinson's and Alzheimer's Diseases. Springer-Verlag, 1990, pp 59-69.

  • Lever J, Dannals R, Wilson A, Ravert H, Scheffel U, et al. Synthesis and in vivo characterization of D-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptors. Int J Radiat Appl Instr B Nucl Med Biol, 16:697-704, 1989.

  • Lever, J, Dannals, R, Wilson, A, Ravert, H, Wagner, H Jr: Synthesis of carbon-11 labeled diprenorphine: A radioligand for positron emission tomographic studies of opiate receptors. Tetrahed Lett, 28:4015-8, 1987.

  • Levivier, M, Goldman, S, Bidaut, L, Luxen, A, et al: Positron emission tomography-guided stereotactic brain biopsy. Neurosurgery 31:792-797, 1992.

  • Lindholm, P, Minn, H, Leskinen-Kallio, S, Bergman, J, Ruotsalainen, U, Joensuu, H: Influence of the blood glucose concentration on FDG uptake in cancer--a PET study. J Nucl Med, 34:1-6, 1993.

  • Lindvall, O: Prospects of transplantation in human neurodegenerative diseases. Trends Neurosci, 14:376-84, 1991.

  • Liu A, Katzenellenbogen J, VanBrocklin H, Mathias C, Welch M. 20-[18F]fluoromibolerone, a positron-emitting radiotracer for androgen receptors: synthesis and tissue distribution studies. J Nucl Med, 32:81-8, 1991.

  • Llacer, J, Veklerov, E, Baxter, LR, Grafton, ST, Griffeth, LK, Hawkins, RA, Hoh, CK, Mazziotta, JC, Hoffman, EJ, Metz, CE: Results of a clinical receiver operating characteristic study comparing filtered backprojection and maximum likelihood estimator images in FDG PET studies. J Nucl Med, 34:1198-1203, 1993.

  • Lucignani, G, Schmidt, K, Moresco, R, Striano, G, Colombo, F, Sokoloff, L, Fazio, F: Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogenous tissues: Theoretical considerations and practical procedure. J Nucl Med, 34:360-369, 1993.

  • Lundqvist H, Stalnacke C, Hartvig P, Langstrom B. Regional and quantitative determination of monoamine oxidase B in the brain using positron emission tomography. Acta Radiol Suppl Stockh, 376:155-6, 1991.

    Let's Play PET, Copyright 1992, 1993 Regents of the University of California
    All Rights Reserved

    [Back to Menu] [Back to Index]